Zelatriazin (TAK-041; NBI-1065846) is a potent and selective GPR139 agonist with an EC 50 of 22 nM. Zelatriazin has the potential for the research of negative symptoms associated with schizophrenia.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GPR139
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。